Ducruet AP[au] - Search Results

Year	Number of Results
2000	2
2001	2
2002	1
2003	2
2005	1
2006	1
2008	1
2009	1
2024	0

1

Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease.

Ducruet AP, Vogt A, Wipf P, Lazo JS. Ducruet AP, et al. Annu Rev Pharmacol Toxicol. 2005;45:725-50. doi: 10.1146/annurev.pharmtox.45.120403.100040. Annu Rev Pharmacol Toxicol. 2005. PMID: 15822194 Review.

2

Dual-specificity phosphatases as targets for antineoplastic agents.

Lyon MA, Ducruet AP, Wipf P, Lazo JS. Lyon MA, et al. Among authors: ducruet ap. Nat Rev Drug Discov. 2002 Dec;1(12):961-76. doi: 10.1038/nrd963. Nat Rev Drug Discov. 2002. PMID: 12461518 Review.

3

Small molecule inhibitors of dual specificity protein phosphatases.

Pestell KE, Ducruet AP, Wipf P, Lazo JS. Pestell KE, et al. Among authors: ducruet ap. Oncogene. 2000 Dec 27;19(56):6607-12. doi: 10.1038/sj.onc.1204084. Oncogene. 2000. PMID: 11426646 Review.

4

Sleuthful pharmacology.

Lazo JS, Ducruet AP, Koldamova RP. Lazo JS, et al. Among authors: ducruet ap. Mol Pharmacol. 2003 Aug;64(2):199-201. doi: 10.1124/mol.64.2.199. Mol Pharmacol. 2003. PMID: 12869623 No abstract available.

5

Microtubule binding and disruption and induction of premature senescence by disorazole C(1).

Tierno MB, Kitchens CA, Petrik B, Graham TH, Wipf P, Xu FL, Saunders WS, Raccor BS, Balachandran R, Day BW, Stout JR, Walczak CE, Ducruet AP, Reese CE, Lazo JS. Tierno MB, et al. Among authors: ducruet ap. J Pharmacol Exp Ther. 2009 Mar;328(3):715-22. doi: 10.1124/jpet.108.147330. Epub 2008 Dec 9. J Pharmacol Exp Ther. 2009. PMID: 19066338 Free PMC article.

6

Regulation of Cdc25A half-life in interphase by cyclin-dependent kinase 2 activity.

Ducruet AP, Lazo JS. Ducruet AP, et al. J Biol Chem. 2003 Aug 22;278(34):31838-42. doi: 10.1074/jbc.M303604200. Epub 2003 Jun 11. J Biol Chem. 2003. PMID: 12801928 Free article.

7

Cellular analysis of disorazole C and structure-activity relationship of analogs of the natural product.

Wipf P, Graham TH, Vogt A, Sikorski RP, Ducruet AP, Lazo JS. Wipf P, et al. Among authors: ducruet ap. Chem Biol Drug Des. 2006 Jan;67(1):66-73. doi: 10.1111/j.1747-0285.2005.00313.x. Chem Biol Drug Des. 2006. PMID: 16492150

8

Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25.

Lazo JS, Aslan DC, Southwick EC, Cooley KA, Ducruet AP, Joo B, Vogt A, Wipf P. Lazo JS, et al. Among authors: ducruet ap. J Med Chem. 2001 Nov 22;44(24):4042-9. doi: 10.1021/jm0102046. J Med Chem. 2001. PMID: 11708908

9

Spatial analysis of key signaling proteins by high-content solid-phase cytometry in Hep3B cells treated with an inhibitor of Cdc25 dual-specificity phosphatases.

Vogt A, Adachi T, Ducruet AP, Chesebrough J, Nemoto K, Carr BI, Lazo JS. Vogt A, et al. Among authors: ducruet ap. J Biol Chem. 2001 Jun 8;276(23):20544-50. doi: 10.1074/jbc.M100078200. Epub 2001 Mar 26. J Biol Chem. 2001. PMID: 11274178 Free article.

10

Identification of new Cdc25 dual specificity phosphatase inhibitors in a targeted small molecule array.

Ducruet AP, Rice RL, Tamura K, Yokokawa F, Yokokawa S, Wipf P, Lazo JS. Ducruet AP, et al. Bioorg Med Chem. 2000 Jun;8(6):1451-66. doi: 10.1016/s0968-0896(00)00069-9. Bioorg Med Chem. 2000. PMID: 10896122

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year